Company intelligence / Profile preview

Parker Hughes Clinics

Roseville, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

Parker Hughes Clinics was a specialized cancer research and treatment center based in Roseville, Minnesota, that integrated clinical care with an internal drug discovery program. Founded by Dr. Fatih Uckun, the organization focused on developing novel therapeutics for hematologic malignancies and solid tumors. The center was notable for its early research into targeted therapies, including small molecule inhibitors of Bruton's tyrosine kinase (BTK) and Janus kinase 3 (JAK3). Despite its scientific contributions, the clinic ceased operations in the mid-2000s following significant legal and financial challenges.

Therapeutic areas: Oncology
Modalities: Small moleculeFusion toxin protein therapy
Industry: Biotech

Beyond the preview

Go deeper on Parker Hughes Clinics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parker Hughes Clinics.

Explore the full profile